Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Pain unpleasantness |
Numerical rating scale in response to exposure to a cold pressor task. |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Primary |
Pain intensity |
Numerical rating scale in response to exposure to a cold pressor task. |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Primary |
Pain tolerance |
How long (in seconds) participants tolerate the cold pressor task with the time starting at the point of immersion and stopping when the hand, wrist and forearm were withdrawn from the refrigerated water. |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Physiological response to pain stimulus |
Heart rate data |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Mechanism: Attention Network Task |
A computer based task that has been developed to allow assessment of the functioning of the three major attentional networks; alerting, orienting, and executive attention. |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Mechanism: Mind Wandering Task |
A computer based task that has been developed to allow assessment of three types of mind wandering. |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Mechanism: Mindfulness |
Five Facet Mindfulness Questionnaire-Short Form |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Mechanism: Pain catastrophizing |
Pain Catastrophizing Scale |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Mechanism: Pain appraisals |
Pain Appraisal Inventory |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Mechanism: Pain-Related Cognitive Processes |
Pain-Related Cognitive Process Questionnaire34 |
Change from Experimental Session 1 (Day 1) to Experimental Session 5 (Day 5) |
|
Secondary |
Mechanism: Hypnotizability |
Stanford Clinical Hypnotizability Scale |
Baseline score at Experimental Session 1 (Day 1) |
|
Secondary |
Mechanism: Pre-treatment expectancies |
Treatment Expectations Questionnaire |
Baseline score at Experimental Session 1 (Day 1) |
|